학술논문

Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy.
Document Type
Article
Source
Frontiers in Endocrinology; 2/24/2021, Vol. 11, pN.PAG-N.PAG, 9p
Subject
PROGNOSIS
NEUTROPHIL lymphocyte ratio
CANCER chemotherapy
PROGRESSION-free survival
METASTASIS
ADRENAL tumors
Language
ISSN
16642392
Abstract
Copyright of Frontiers in Endocrinology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)